Hybrid Event
19-21 May 2026Steigenberger Icon Wiltcher's, Brussels, BEHybrid Event
19-21 May 2026,
Steigenberger Icon Wiltcher's, Brussels, BE
19-21 May 2026,
Steigenberger Icon Wiltcher's, Brussels, BE
Thursday 21 May 2026
Bolster Commercial Agreements with Insights on Navigating Trump 2.0 Policies and MFN Clauses. Learn to Structure Licensing Deals, Collaborate with Asian BioTech Innovators, and Unlock BioTech Seed Innovation.
Commercial Transactions | What's On?
Global Deal Trends and Transaction Challenges in Life Sciences
- Explore expected deal trends for 2026/2027 amid evolving market conditions
- Address challenges from the EU Pharma Package and shifting regulatory exclusivity
- Identify hot investment areas in the life sciences sector
- Navigate new deal structures for Asian biotech markets
Licensing Deals in a Changing Regulatory Landscape
- Review key antitrust milestones and their impact on commercial transactions
- Manage foreign investment and antitrust issues in cross-border collaborations
- Navigate MFN clauses in US in-licensing agreements amid global policy shifts
- Negotiate Access to Medicine license agreements with strategic considerations
Conflict Management and Dispute Resolution in Commercial Deals
- Safeguard contracts with duress and force majeure provisions during political shifts
- Address conflicts of interest in collaborative commercial partnerships
- Alternative dispute resolution methods: baseball arbitration and expert determinations
- Balance sensitive information sharing within robust legal and regulatory frameworks
Discover What Else is on the Agenda for 2026!
